Marie Curie Lectures
’18: V. Villemagne (Germany)
Tau PET Imaging: A History of Challenges and Success | Watch Session
’17: U. Haberkorn (Germany)
PSMA Labelled with Alfa-Emitters | Watch Session
’16: S. Barrington (United Kingdom)
PET/CT in Malignant Lymphoma | Watch Session
’15: S. Fanti (Italy)
Prostate Cancer | Watch Session
’14: M.J. Schlumberger (France)
Treatment of Differentiated Thyroid Cancer – State of the Art and New Developments | Watch Session
’13: J.J. Bax (Netherlands)
Imaging of Coronary Artery Disease: Stenosis versus Perfusion
’12: V. Grégoire (Belgium)
Molecular Imaging Based Radiotherapy for Head and Neck Cancer
’11: A. J. McEwan (Canada)
The Future of Molecular Imaging in Enhancing Cancer Care
’10: I. Modlin (USA)
From Polonium to Lutetium: The Neuroendocrine Legacy of Curie
’09: V. Fuster (USA)
Diagnosing early atherothrombotic disease in the XXI century
’08: H. Maecke (Switzerland)
Therapeutic Radiopharmaceuticals
’07: I. Carrio (Spain)
Nuclear Medicine Research in old and new Europe
’06: R. Dierckx (The Netherlands)
Ta panta rei
’05: J. Knuuti (Finland)
Imaging of oxidative Metabolism: Insight into Cardiac Performance
’04: M. Schwaiger (Germany)
Prospects of PET and PET/CT in Cardiology
’03: E.P. Krenning (The Netherlands)
Radiolabelled peptides in oncology: present status and future directions.
’02: A. Cuocolo (Italy)
The Role of Nuclear Medicine in Clinical Decision making in Cardiology.
’01: P. Lind (Austria)
Treatment with radiopharmaceuticals: benign diseases
’00: P. Bourguet (France)
IRT: palliative or curative?
’99: G. Paganelli (Italy)
Sentinel node biopsy in breast cancer: from pilot study to randomized trial
’98: R.L. Wahl (Germany)
New therapies in Nuclear Medicine
’97: J.L. Moretti (France)
Updated applications and new trends in cerebral perfusion tracers